In the past decade, kidney disease diagnosed with objective measures of kidney damage
and function has been recognised as a major public health burden. The population …

The link between vascular calcification (VC) and increased mortality is now well established.
Over time, as clinical importance of this phenomenon has begun to be fully considered …

Hyperphosphatemia is common in patients with chronic kidney disease and is increasingly
associated with poor clinical outcomes. Current management of hyperphosphatemia with …

Cisplatin (CP)-induced nephrotoxicity is widely accepted as a model for acute kidney injury
(AKI). Although cisplatin-induced chronic kidney disease (CKD) in rodent has been reported …

In CKD, phosphate retention arising from diminished GFR is a key early step in a pathologic
cascade leading to hyperthyroidism, metabolic bone disease, vascular calcification, and …

Hyperphosphatemia is the primary risk factor for vascular calcification, which is closely
associated with cardiovascular morbidity and mortality. Recent evidence showed that …

Background Benefits of phosphate-lowering interventions on clinical outcomes in patients
with CKD are unclear; systematic reviews have predominantly involved patients on dialysis …

Background Hyperphosphataemia is an independent risk factor for accelerated
cardiovascular disease in chronic kidney disease (CKD), although the mechanism for this is …

Vascular calcification is commonly observed in chronic kidney disease. The mechanism of
how the calcification signal from endothelial cells is transmitted to vascular smooth muscle …

Risk factors for heart valve calcification in chronic kidney... : Medicine Risk factors for heart
valve calcification in chronic kidney disease : Medicine Log in or Register Get new issue …